Outset Medical Statistics
Share Statistics
Outset Medical has 52.94M shares outstanding. The number of shares has increased by 4.03% in one year.
| Shares Outstanding | 52.94M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.87% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 48.67M |
| Failed to Deliver (FTD) Shares | 8.00K |
| FTD / Avg. Volume | 0.79% |
Short Selling Information
The latest short interest is 2.62M, so 4.99% of the outstanding shares have been sold short.
| Short Interest | 2.62M |
| Short % of Shares Out | 4.99% |
| Short % of Float | 5.43% |
| Short Ratio (days to cover) | 3.29 |
Valuation Ratios
The PE ratio is -1.55 and the forward PE ratio is -0.65.
| PE Ratio | -1.55 |
| Forward PE | -0.65 |
| PS Ratio | 2.06 |
| Forward PS | 0.3 |
| PB Ratio | 2.18 |
| P/FCF Ratio | -1.99 |
| PEG Ratio | n/a |
Enterprise Valuation
Outset Medical Inc. has an Enterprise Value (EV) of 335.95M.
| EV / Earnings | -1.94 |
| EV / Sales | 2.58 |
| EV / EBITDA | -2.18 |
| EV / EBIT | -1.98 |
| EV / FCF | -2.49 |
Financial Position
The company has a current ratio of 5.26, with a Debt / Equity ratio of 1.11.
| Current Ratio | 5.26 |
| Quick Ratio | 4.37 |
| Debt / Equity | 1.11 |
| Total Debt / Capitalization | 52.57 |
| Cash Flow / Debt | -0.96 |
| Interest Coverage | -13.39 |
Financial Efficiency
Return on equity (ROE) is -1.41% and return on capital (ROIC) is -65.73%.
| Return on Equity (ROE) | -1.41% |
| Return on Assets (ROA) | -0.55% |
| Return on Capital (ROIC) | -65.73% |
| Revenue Per Employee | 271.62K |
| Profits Per Employee | -359.99K |
| Employee Count | 480 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.06 |
Taxes
| Income Tax | 523.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -80.43% in the last 52 weeks. The beta is 1.95, so Outset Medical 's price volatility has been higher than the market average.
| Beta | 1.95 |
| 52-Week Price Change | -80.43% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 1.98 |
| Relative Strength Index (RSI) | 38.18 |
| Average Volume (20 Days) | 1.01M |
Income Statement
In the last 12 months, Outset Medical had revenue of 130.38M and earned -172.80M in profits. Earnings per share was -3.48.
| Revenue | 130.38M |
| Gross Profit | 29.00M |
| Operating Income | -169.77M |
| Net Income | -172.80M |
| EBITDA | -153.79M |
| EBIT | -169.77M |
| Earnings Per Share (EPS) | -3.48 |
Balance Sheet
The company has 68.51M in cash and 136.19M in debt, giving a net cash position of -67.68M.
| Cash & Cash Equivalents | 68.51M |
| Total Debt | 136.19M |
| Net Cash | -67.68M |
| Retained Earnings | -961.75M |
| Total Assets | 292.89M |
| Working Capital | 232.84M |
Cash Flow
In the last 12 months, operating cash flow was -131.37M and capital expenditures -3.44M, giving a free cash flow of -134.81M.
| Operating Cash Flow | -131.37M |
| Capital Expenditures | -3.44M |
| Free Cash Flow | -134.81M |
| FCF Per Share | -2.72 |
Margins
Gross margin is 22.24%, with operating and profit margins of -130.22% and -132.54%.
| Gross Margin | 22.24% |
| Operating Margin | -130.22% |
| Pretax Margin | -132.14% |
| Profit Margin | -132.54% |
| EBITDA Margin | -117.96% |
| EBIT Margin | -130.22% |
| FCF Margin | -103.4% |
Dividends & Yields
OM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -429.63% |
| FCF Yield | -312.9% |
Analyst Forecast
The average price target for OM is $3, which is 270.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $3 |
| Price Target Difference | 270.4% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -4.92 |
| Piotroski F-Score | 3 |